Cell type, Hodgkin lymphoma, Lymphoma
Results
Phase 2
This trial was for people with Hodgkin lymphoma that had come back after:
a stem cell transplant using their own cells (autologous stem cell transplant)
treatment with the brentuximab
Recruitment start: 14 October 2014
Recruitment end: 25 August 2015
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor John Radford
Bristol-Myers Squibb
NIHR Clinical Research Network: Cancer
Last reviewed: 26 Jun 2018
CRUK internal database number: 12477
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
